News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Gianrico Farrugia: We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.
Photo from Gianrico Farrugia/LinkedIn
Aug 21, 2023, 17:03

Gianrico Farrugia: We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.

“We must shift the standard of care to focus more on best meeting a patient’s distinct needs, no matter where they are.

Fortune highlights the spread of modern hospital-at-home programs in America, including Mayo’s model to provide options for patients to receive high-quality care outside of a hospital building.”
For details click here.
cancer Fortune Gianrico Farrugia LinkedIn Mayo Clinic OncoDaily Oncology
Special Coverage
Blog
Feb 22, 2025, 16:04
Eric Lehrer: Role of WBRT in multifocal LGG
Science
Feb 22, 2025, 16:00
Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM
Blog
Feb 22, 2025, 15:54
Patrick Forde: Great day for lung cancer care
Science
Feb 22, 2025, 15:48
Shankar Siva: Whats new in stage IV cancer?
Science
Feb 22, 2025, 15:33
Updated ESMO Clinical Practice Guideline on Hepatocellular Carcinoma
Science
Feb 22, 2025, 15:14
Erman Akkus: Stage specific characterization of early-onset colorectal cancer
Blog
Feb 22, 2025, 15:04
John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"
Blog
Feb 22, 2025, 14:43
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Science
Feb 22, 2025, 14:10
Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach
Science
Feb 22, 2025, 13:28
Elvina Almuradova: Immunotherapy for HPV-Associated Cancers
Opinion
Feb 22, 2025, 13:10
Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding
Science
Feb 22, 2025, 13:10
Why immunotherapy has struggled in EGFR+ lung cancer - EGFR Positive Lung Cancer UK